questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrionaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Tumor Necrosis Factor-alpha
Diagnostic
5
Infections bactériennes
Culture bactérienne
Tests sérologiques
Infections bactériennes
Caractéristiques morphologiques
Tests biochimiques
Symptômes
5
Déshydratation
Choc hypovolémique
Infections asymptomatiques
Porteurs sains
Prévention
5
Sécurité alimentaire
Fruits de mer
Voyage
Précautions sanitaires
Hygiène des mains
Prévention des infections
Traitements
5
Antibiotiques
Infections bactériennes
Solutions de réhydratation
Déshydratation
Traitements symptomatiques
Antiémétiques
Complications
5
Déshydratation
Insuffisance rénale
Choléra
Choc hypovolémique
Infections mortelles
Vulnérabilité
Gestion des complications
Réhydratation
Personnes âgées
Complications
Facteurs de risque
5
Fruits de mer
Eau contaminée
Immunodépression
Infections graves
Climat
Infections bactériennes
Voyages
Risque d'infection
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrionaceae : Questions médicales les plus fréquentes",
"headline": "Vibrionaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrionaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrionaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gammaproteobacteria",
"url": "https://questionsmedicales.fr/mesh/D020563",
"about": {
"@type": "MedicalCondition",
"name": "Gammaproteobacteria",
"code": {
"@type": "MedicalCode",
"code": "D020563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio",
"alternateName": "Aliivibrio",
"url": "https://questionsmedicales.fr/mesh/D059706",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio",
"code": {
"@type": "MedicalCode",
"code": "D059706",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio fischeri",
"alternateName": "Aliivibrio fischeri",
"url": "https://questionsmedicales.fr/mesh/D048908",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio fischeri",
"code": {
"@type": "MedicalCode",
"code": "D048908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.860"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aliivibrio salmonicida",
"alternateName": "Aliivibrio salmonicida",
"url": "https://questionsmedicales.fr/mesh/D044165",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio salmonicida",
"code": {
"@type": "MedicalCode",
"code": "D044165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.930"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Listonella",
"alternateName": "Listonella",
"url": "https://questionsmedicales.fr/mesh/D053526",
"about": {
"@type": "MedicalCondition",
"name": "Listonella",
"code": {
"@type": "MedicalCode",
"code": "D053526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Photobacterium",
"alternateName": "Photobacterium",
"url": "https://questionsmedicales.fr/mesh/D010776",
"about": {
"@type": "MedicalCondition",
"name": "Photobacterium",
"code": {
"@type": "MedicalCode",
"code": "D010776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio",
"alternateName": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio alginolyticus",
"alternateName": "Vibrio alginolyticus",
"url": "https://questionsmedicales.fr/mesh/D044149",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio alginolyticus",
"code": {
"@type": "MedicalCode",
"code": "D044149",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"url": "https://questionsmedicales.fr/mesh/D014734",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio mimicus",
"alternateName": "Vibrio mimicus",
"url": "https://questionsmedicales.fr/mesh/D044164",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio mimicus",
"code": {
"@type": "MedicalCode",
"code": "D044164",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio parahaemolyticus",
"alternateName": "Vibrio parahaemolyticus",
"url": "https://questionsmedicales.fr/mesh/D014736",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio parahaemolyticus",
"code": {
"@type": "MedicalCode",
"code": "D014736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio vulnificus",
"alternateName": "Vibrio vulnificus",
"url": "https://questionsmedicales.fr/mesh/D041261",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio vulnificus",
"code": {
"@type": "MedicalCode",
"code": "D041261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrionaceae",
"alternateName": "Vibrionaceae",
"code": {
"@type": "MedicalCode",
"code": "D014737",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chunqi Jiang",
"url": "https://questionsmedicales.fr/author/Chunqi%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Sayaka Mino",
"url": "https://questionsmedicales.fr/author/Sayaka%20Mino",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Jesús L Romalde",
"url": "https://questionsmedicales.fr/author/Jes%C3%BAs%20L%20Romalde",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Microbiología y Parasitología, CRETUS & CIBUS-Facultad de Biología, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, España."
}
},
{
"@type": "Person",
"name": "Tomoo Sawabe",
"url": "https://questionsmedicales.fr/author/Tomoo%20Sawabe",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan. sawabe@fish.hokudai.ac.jp."
}
},
{
"@type": "Person",
"name": "William Soto",
"url": "https://questionsmedicales.fr/author/William%20Soto",
"affiliation": {
"@type": "Organization",
"name": "Integrated Science Center Rm 3035, Department of Biology, College of William & Mary, 540 Landrum Dr., Williamsburg, VA 23185, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tumor necrosis factor-alpha blockade suppresses BK polyomavirus replication.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36512270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s15010-022-01962-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37483590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1213448"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35857191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40264-022-01210-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37407724",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13679-023-00519-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of anti-tumor necrosis factor-alpha agents in treatment of sarcoidosis: A meta-analysis.",
"datePublished": "2022-12-14",
"url": "https://questionsmedicales.fr/article/36526497",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.12.003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrionaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrionaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrionaceae",
"description": "Comment diagnostiquer une infection par Vibrionaceae ?\nQuels tests sont utilisés pour identifier Vibrio cholerae ?\nLes tests sérologiques sont-ils utiles pour Vibrionaceae ?\nQuels symptômes indiquent une infection vibrionique ?\nComment différencier Vibrionaceae d'autres bactéries ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Tumor+Necrosis+Factor-alpha#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrionaceae",
"description": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?\nLes infections vibrioniques causent-elles des vomissements ?\nY a-t-il des symptômes graves associés aux Vibrionaceae ?\nLes symptômes apparaissent-ils rapidement après infection ?\nLes infections vibrioniques peuvent-elles être asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Tumor+Necrosis+Factor-alpha#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrionaceae",
"description": "Comment prévenir les infections par Vibrionaceae ?\nLes vaccins existent-ils contre Vibrionaceae ?\nQuelles mesures de sécurité alimentaire sont recommandées ?\nLes voyageurs doivent-ils prendre des précautions ?\nL'hygiène des mains est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Tumor+Necrosis+Factor-alpha#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrionaceae",
"description": "Quel est le traitement principal pour les infections par Vibrionaceae ?\nLes antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?\nComment prévenir la déshydratation dans les infections vibrioniques ?\nLes traitements symptomatiques sont-ils efficaces ?\nY a-t-il des traitements spécifiques pour le choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Tumor+Necrosis+Factor-alpha#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrionaceae",
"description": "Quelles complications peuvent survenir avec Vibrionaceae ?\nLe choléra peut-il entraîner des complications graves ?\nLes infections vibrioniques peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes personnes âgées sont-elles plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Tumor+Necrosis+Factor-alpha#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrionaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles à risque ?\nLe climat influence-t-il le risque d'infection ?\nLes enfants sont-ils plus vulnérables ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Tumor+Necrosis+Factor-alpha#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrionaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne à partir d'échantillons de selles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Vibrio cholerae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des méthodes moléculaires comme la PCR sont utilisés."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles pour Vibrionaceae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont généralement pas utilisés pour le diagnostic des infections vibrioniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection vibrionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, les vomissements et la déshydratation peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment différencier Vibrionaceae d'autres bactéries ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse des caractéristiques morphologiques et des tests biochimiques aide à la différenciation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, crampes abdominales et fièvre."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques causent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements sont fréquents, surtout dans les cas de choléra."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves associés aux Vibrionaceae ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves incluent la déshydratation sévère et le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement après infection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être asymptomatiques, surtout chez les porteurs sains."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Vibrionaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène, la cuisson des aliments et l'eau potable."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre Vibrionaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un vaccin contre le choléra est disponible, mais pas pour toutes les espèces de Vibrionaceae."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité alimentaire sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de bien cuire les fruits de mer et de ne pas consommer d'eau non traitée."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils prendre des précautions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des zones à risque doivent être prudents avec l'eau et la nourriture."
}
},
{
"@type": "Question",
"name": "L'hygiène des mains est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se laver les mains régulièrement est crucial pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections par Vibrionaceae ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation orale ou intraveineuse est le traitement principal, surtout pour le choléra."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être prescrits dans les cas graves, mais ne sont pas toujours nécessaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans les infections vibrioniques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration rapide de solutions de réhydratation est essentielle pour prévenir la déshydratation."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements symptomatiques comme les antiémétiques peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour le choléra ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques spécifiques et des solutions de réhydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Vibrionaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la déshydratation sévère, le choc et l'insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut entraîner des complications graves comme le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être mortelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement approprié, les infections peuvent être mortelles, surtout chez les vulnérables."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par une réhydratation rapide et un traitement médical approprié."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque accru d'infections graves."
}
},
{
"@type": "Question",
"name": "Le climat influence-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Vibrionaceae sont plus fréquentes dans les climats chauds et humides."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux infections et à leurs complications."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à risque augmente la probabilité d'infection par Vibrionaceae."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 14/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan.
Publications dans "Vibrionaceae" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan.
Publications dans "Vibrionaceae" :
2 publications dans cette catégorie
Affiliations :
Departamento de Microbiología y Parasitología, CRETUS & CIBUS-Facultad de Biología, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, España.
Publications dans "Vibrionaceae" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan. sawabe@fish.hokudai.ac.jp.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Integrated Science Center Rm 3035, Department of Biology, College of William & Mary, 540 Landrum Dr., Williamsburg, VA 23185, USA.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Faculty of Science, Universiti Putra Malaysia, and Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia, and Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Aquaculture, Faculty of Agriculture, Universiti Putra Malaysia, and Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
International Institute for Halal Research and Training, International Islamic University Malaysia, 53100 Gombak, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid 28049, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid 28049, Spain.
Centro de Investigación Biológica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid 28222, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
BK Polyomavirus (BKPyV) infection manifests as renal inflammation and can cause kidney damage. Tumor necrosis factor-α (TNF-α) is increased in renal inflammation and injury. The aim of this study was ...
Urine specimens from 22 patients with BKPyV-associated nephropathy (BKPyVN) and 35 non-BKPyVN kidney transplant recipients were analyzed....
We demonstrated increased urinary levels of TNF-α and its receptors, TNFR1 and TNFR2, in BKPyVN patients. Treating BKPyV-infected human proximal tubular cells (HRPTECs) with TNF-α stimulated the expre...
TNF-α stimulates BKPyV replication and inhibition of its signal cascade or functionality attenuates its stimulatory effect. Our study provides a therapeutic anti-BKPyV target....
Tumor necrosis factor-alpha (TNF-α) is a pleiotropic immune cytokine that belongs to the TNF superfamily of receptor ligands. The cytokine exists as either a transmembrane or a soluble molecule, and t...
An association between tumor necrosis factor (TNF)-α inhibitors and hypoglycemia has been detected in a few case reports and small case series; however, no relevant pharmacovigilance data have been pu...
The objective of this study was to detect and characterize relevant safety signals between hypoglycemia and TNF-α inhibitor use....
Indication-focused disproportionality analysis was conducted to detect increased reporting of TNF-α-associated hypoglycemia compared with all other reports with the same indication during the same tim...
In all, 1086 adverse drug reactions related to TNF-α inhibitors were reported as 'hypoglycemia'. There were no disproportionality signals of hypoglycemia in TNF-α inhibitor users with indication of in...
Our study identified some potential pharmacovigilance signals between hypoglycemia and TNF-α inhibitors, which warrants further validation....
To summarize experimental and clinical evidence on the association between tumor necrosis factor-α (TNF-α) and nonalcoholic fatty liver disease (NAFLD) and discuss potential treatment considerations....
Experimental evidence suggests that TNF-α is a cytokine with a critical role in the pathogenesis of NAFLD. Although, the production of TNF-α may be an early event during the course of nonalcoholic fat...
Anti-tumor necrosis factor-alpha agent (anti-TNF-α) is considered an effective third-line therapy for refractory sarcoidosis,studies observing the efficacy of anti-TNF-α agents show conflicting result...
We performed an up-to-date systemic meta-analysis to determine effectiveness and further elucidate the role of anti-TNF-α in the treatment of sarcoidosis....
A systematic search was carried out in PubMed/Medline, EMBASE, and Cochrane Library for studies reporting the therapeutic effects of anti-TNF drugs on patients with pulmonary and extra-pulmonary sarco...
Clinical trials written reporting the therapeutic effects of anti-TNF drugs on patients with pulmonary and extra-pulmonary sarcoidosis were included....
Statistical analyses were performed with Comprehensive Meta-Analysis software, and the random-effects model was used. The combined overall treatment success was determined for patients with pulmonary ...
Overall treatment success rate wasdefined as no disease progression or improvement in symptoms....
Eight clinical trial articles were included in the meta-analysis; four used Infliximab, two Etanercept, one Adalimumab, and one Ustekinumab and Golimumab. The mean age of participants was 48.5 years. ...
Treatment of refractory sarcoidosis with anti-TNF-α agents was effective in both pulmonary and extrapulmonary sarcoidosis, with a slightly higher efficacy seen in extrapulmonary sarcoidosis. Further r...
At present, the occurrence and development of inflammatory diseases are closely related to the abnormal changes of the content and function of many cytokines. At the same time, targeting related cytok...
Lymphatic metastasis is a common phenomenon of cervical cancer. Tumor necrosis factor-...
In this study, cervical cancer cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with or without TNF-...
We found that TNF-...
Collectively, TNF-...
Pulmonary injury induced by mustard vesicants and radiation is characterized by DNA damage, oxidative stress, and inflammation. This is associated with increases in levels of inflammatory mediators, i...
The role of inflammatory cytokines, such as tumor necrosis-α (TNF-α) and IL-8, in gastric carcinogenesis has been investigated, but their impact remains to be further elucidated....
In this study, we measured the serum concentrations of these cytokines and H. pylori serostatus in dyspeptic patients, presenting with normal mucosa (NM = 53), chronic gastritis (CG = 94), and gastric...
Moderate levels of TNF-α were detected in the NM group (19.9 ± 19.5 pg/ml), which were nearly doubled in patients with CG (35.7 ± 28.0 pg/ml) and drastically declined in GC patients (1.8 ± 5.9 pg/ml)....
TNF-α serum concentration seemed to undergo up- and downregulation, when moving from NM to CG and from CG to GC, respectively. If confirmed in a prospective study, this cytokine can behave as a serum ...
We prepared three-dimensional (3-D) organoids of human stomach cancers and examined the correlation between the tumorigenicity and cytotoxicity of...